Feedback / Questions
VS-041 - Vasa Therapeutics
https://www.prnewswire.com/news-releases/vasa-therapeutics-granted-fda-fast-track-designation-for-vs-041-a-novel-investigational-treatment-of-heart-failure-with-preserved-ejection-fraction-hfpef-302618309.html
Nov 18, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next